Bulletin from Moberg Pharma’s AGM on May 14[th], 2024
STOCKHOLM, May 14[th], 2024. Moberg Pharma AB (publ)’s (“Moberg Pharma” or the “Company”) Annual General Meeting took place today. The Annual General Meeting resolved in accordance with the Nomination Committee’s and Board of Directors’ proposals as set out below.Adoption of the income statements and the balance sheetsThe Annual General Meeting approved the income statements and the balance sheets for the fiscal year 2023. The Annual General Meeting resolved, in accordance with the proposal of the Board of Directors that no dividend should be paid for the fiscal year 2023. The